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Background: Primary lung cancer is extremely rare in children, while secondary malignancies reportedly develop in
2% to 3% of pediatric osteosarcoma survivors.
Case presentation: A 14-year-old girl was found to have two pulmonary lesions on computed tomography. These
tumors had developed 1 year after osteosarcoma surgery. Segmentectomy of right segment 1 and wedge resection
of right segment 9 were performed. Both lesions were completely resected and postoperative histopathological
examination revealed metastasis of osteosarcoma and bronchioloalveolar carcinoma, respectively.
Conclusion: Bronchioloalveolar carcinoma may present as a solitary pulmonary lesion indistinguishable from a
metastatic lesion and should be included in the differential diagnosis of pulmonary lesions in survivors of pediatric
cancer. Thus, pulmonary lesions identified in these patients should be biopsied or resected to establish a
histological diagnosis.Background
Osteosarcoma accounts for approximately 3% of all
pediatric malignancies. With current multi-modal ap-
proaches, 70% of patients can achieve long-term survival
[1]. The lungs are a common site of recurrence, and
close follow-up with imaging studies is mandatory [2].
The differential diagnosis of new lung lesions in survi-
vors of osteosarcoma usually includes disease recurrence
versus inflammatory lesions, such as granulomatous dis-
ease [3], but the possibility of a second malignancy is
seldom considered. Herein, we present a surgical case of
bronchioloalveolar carcinoma (BAC) found simultan-
eously with pulmonary metastasis of osteosarcoma. The
patient was a 14-year-old girl.Case presentation
A 14-year-old girl was found to have an abnormal shadow
on a chest X-ray during postoperative follow-up for osteo-
sarcoma of the upper end of the left tibia (Figure 1A), and
was referred to our department in June 2011. Chest* Correspondence: taichiro@1997.jukuin.keio.ac.jp
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reproduction in any medium, provided the orcomputed tomography (CT) showed a 35-mm tumor in
right segment 1 (S1) and a 3-mm ground glass opacity
(GGO) in right segment 9 (S9) (Figures 1B, 2B). Positron
emission tomography (PET) showed fluorodeoxyglucose
(FDG) uptake with a maximum standardized uptake value
of 7.8 only in the right S1 tumor without evidence of
metastatic foci elsewhere in the body (Figure 1C). Blood
chemistry data were unremarkable, and the carcinoem-
bryonic antigen and squamous cell carcinoma-related
antigen were within normal limits. She was otherwise in
good health. Her family history was unremarkable and
negative for cancer.
As to the past history of this patient, from January
2010 to June 2010, under a diagnosis of osteosarcoma of
the left tibia, she had received chemotherapy, including
cisplatin + pirarubicin, high dose methotrexate, and high
dose ifosfamide. Then, wide resection of the upper end
of the left tibia was performed in July 2010. Although
chest CT at that time showed no tumor in the right S1,
a tiny and extremely faint shadow was observed in the
right S9 (Figure 2A).
The right S1 tumor had a relatively smooth surface
and showed rapid growth. PET showed FDG uptake, and
pulmonary metastasis of osteosarcoma was suspected.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Radiological findings of pulmonary metastasis of osteosarcoma. (A) Chest X-ray shows an abnormal shadow in the right upper
lung field. (B) Chest CT reveals a 35-mm tumor with a relatively smooth surface in right S1. (C) PET shows FDG uptake by the tumor.
Figure 2 Radiological findings of bronchioloalveolar carcinoma. (A) Chest CT just before the left tibia surgery showed an extremely faint,
small shadow in right S9. (B) When the patient was referred to our department 1 year later, chest CT revealed a 3-mm GGO at the same site.
Figure 3 Gross examination of the resected specimens. (A) Right S1 tumor. (B) Right S9 lesion. Arrow indicates the S9 lesion.
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Figure 4 Histopathological findings. (A) Microscopic examination of the right S1 tumor confirmed a sarcoma composed of fascicular proliferation
of spindle-shaped cells. (B, C) In the right S9 lesion, atypical cuboidal cells grew densely along alveolar walls, forming a bronchioloalveolar pattern.
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tle tendency to grow (Figure 2), and there was no FDG
uptake on PET. Given also the morphology of the lesion
and the patient’s age, we considered the GGO to likely be
an inflammatory lesion. At surgery, right S1 segmentectomy
and wedge resection of right S9 were performed.
The right S1 tumor was firm, with a diameter of
3.7 cm, and the cut surface was white and glistening
(Figure 3A). Many cavities containing mucus were ob-
served inside the tumor. Postoperative histopathological
examination revealed spindle-shaped cells arranged densely
in fascicles (Figure 4A). These cells exhibited abundant
eosinophilic cytoplasm and marked nuclear pleomorphism.
The tumor tissues were in part admixed with eosinophilic
osteoid stroma (Figure 4A). The histology of the tumor
was similar to that of the osteosarcoma resected previously.
On the other hand, the right S9 lesion was an aerated
whitish tumor, 3 mm in diameter with macroscopically ill-
defined margins (Figure 3B). Histopathological examin-
ation revealed the alveolar walls to be densely covered with
atypical cuboidal cells with enlarged nuclei, forming a
bronchioloalveolar pattern (Figure 4B,C). There was no
interstitial infiltration of the tumor cells. Cytologically, the
cells were characterized by finely granular chromatin andTable 1 Studies on second malignant neoplasms in childhood
Author/Year Osteosarcomas (n) SMN (n)
Pratt [14] 1997 334 9 (2.6%)
Anug [13] 2002 509 14 (2.7%)
Bacci [12] 2006 1205 26 (2.2%)
SMN, second malignant neoplasms.conspicuous nucleoli, with atypia. Thus, the lesion was di-
agnosed as non-mucinous and localized BAC without foci
of collapse or invasive growth. The tumor cells were posi-
tive for thyroid transcription factor-1, pan-cytokeratin, and
epithelial membrane antigen. The MIB-1 labeling index
was low at approximately 1%. The resected margins of
both the right S1 and the right S9 tumor were free of ma-
lignant cells.
The patient had an uneventful postoperative course, and
was discharged on the 7th postoperative day. Chemother-
apy with high-dose ifosfamide has been performed at
the Department of Orthopedics of our hospital. At present,
16 months after lung surgery, she remains recurrence free.
Discussion
The incidence of primary pediatric lung cancers is ex-
tremely low [4]. Histologically, bronchial adenoma (40%),
bronchogenic carcinoma (17%), and pleuropulmonary
blastoma (16%) are the common types [4]. BAC is one such
rare form of pediatric pulmonary malignancy, but no clear
association between BAC and environmental exposure has
been established [5]. One identified association is a link be-
tween BAC and congenital adenomatoid cystic malforma-
tion Type I, particularly with mucinous metaplasia [5-7].osteosarcoma survivors




Table 2 Case reports on primary lung cancer in childhood osteosarcoma survivors
Author/Year Age (years) Gender Primary lesion Lung cancer histology
Nonomura [19] 1994 13 Female Right fibula Adenocarcinoma
Kobayashi [16] 1999 14 Male Left femur Adenocarcinoma
Longhi [18] 2004 17 Female Right tibia Adenocarcinoma
Lebensburger [17] 2009 8 Male Right fibula BAC
Lebensburger [17] 2009 12 Female Right fibula BAC
Shiraishi [20] 2010 17 Male Left humerus BAC
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nancy have been reported among survivors of pediatric ma-
lignancies, including Ewing sarcoma, Hodgkin’s lymphoma,
hepatoblastoma, and testicular teratocarcinoma [8-11]. As
in this case, the occurrence of BAC in a child with another
primary malignant tumor treated with chemotherapy or ra-
diation therapy raises the possibility that BAC is linked to
therapeutic or immunosuppressive factor, in addition to a
genetic predisposition.
Although the overall incidence of second malignant
neoplasms in survivors of pediatric osteosarcomas is
relatively low, it is higher compared with the expected
incidence of malignant neoplasm in the general popula-
tion [12-14]. Institutional reviews have found the rate of
second malignant neoplasms in survivors of pediatric
osteosarcomas to be between 2% and 3% (Table 1) [12-14].
Pratt et al. reviewed 334 patients with osteosarcoma and
found that second malignant neoplasms had developed in
nine (2.6%) [14]. Anug et al. reviewed 509 patients with
osteosarcoma and documented second malignant neo-
plasms in 14 (2.7%) [13]. No cases with primary lung neo-
plasms were found in either of these reviews [13,14]. In a
review of 1,205 patients with osteosarcoma of the extrem-
ities, Bacci et al. described 26 (2.2%) who had developed a
second malignant neoplasm [12]. Two of these 26 patients
developed lung cancers, one adenocarcinoma and one
squamous cell carcinoma at 4 and 9 years, respectively,
after the osteosarcoma diagnosis. Several studies have
demonstrated that female gender and being at least 10
years of age, as in our case, proved to be independent risk
factors for the development of a second malignant neo-
plasm [12,15].
Case reports on primary lung cancer arising in survi-
vors of pediatric osteosarcoma are shown in Table 2
[16-20]. Six cases have been reported to date. In all six,
the diagnosis was confirmed by surgical resection of the
pulmonary tumor. The majority of these patients were at
least 10 years old. There were three boys and three girls.
The histological type was adenocarcinoma in all cases
(including BAC in three cases).
Icard et al. reported the 5-year survival rate for stage I
pulmonary lung cancer in young patients to be 70%which is not quite different from that for lung cancer in
elderly patients, and that the survival rate depends on
disease stage rather than age [21]. Thus, surgical resec-
tion is the treatment of choice for pediatric BAC, as for
adult BAC. In our case, additional resection was not
performed after wedge resection based on the pathological
examination results. Given that BAC or pulmonary metas-
tasis of osteosarcoma may occur metachronously in the
future, meticulous outpatient follow-up is planned.
Conclusion
In conclusion, we have described a very rare BAC in a
14-year-old girl with recurrent osteosarcoma. It is inter-
esting that most of these rare pediatric BAC have oc-
curred in children who had another malignant tumor,
raising the possibility of a link between these entities.
Additionally, our present patient illustrates the impor-
tance of establishing a histopathological diagnosis for
suspected pulmonary metastases in children with known
primary malignant tumors.
Consent
Written informed consent was obtained from the patient
for the publication of this case presentation and accom-
panying images. A copy of the written consent is avail-
able for review by the Editor-in-Chief of this journal.
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